Chief Executive Officer
Pine Health Strategies, Llc
AeroLeads people directory · profile
Michael Pine Email & Phone Number
Chief Executive Officer
at
Pine Health Strategies, LLC
1 work email found
@eyepointpharma.com
10 phones found area 212, 718, 732, 914, 516, 607, and 862
LinkedIn matched
✓ Verified Jul 2026
4 data sources
Profile completeness 100%
Current company
Role
Chief Executive Officer
Location
New York City Metropolitan Area, United States
Who is Michael Pine? Overview
A concise factual answer block for searchers comparing this professional profile.
Quick answer
Michael Pine is listed as Chief Executive Officer at Pine Health Strategies, LLC, based in New York City Metropolitan Area, United States. AeroLeads shows a work email signal at eyepointpharma.com, phone signal with area code 212, 718, 732, 914, 516, 607, 862, and a matched LinkedIn profile for Michael Pine.
Michael Pine previously worked as Chief Business Officer at Eyepoint Pharmaceuticals and Chief Corporate Development & Strategy Officer at Eyepoint Pharmaceuticals. Michael Pine holds Mba, Strategy, Marketing, Management, Finance from Columbia Business School.
Company email context
Email format at Pine Health Strategies, LLC
This section adds company-level context without repeating Michael Pine's masked contact details.
{first_initial}{last}@eyepointpharma.com
86% confidence
AeroLeads found 1 current-domain work email signal for Michael Pine. Compare company email patterns before reaching out.
Profile bio
About Michael Pine
Over 20 years of relevant experience in small, medium and large pharmaceutical companies as a business leader, building a deep and broad C-Suite pharmaceutical executive skill set that includes: Strategy, Leadership, BD&L Negotiations, BD&L Search & Evaluation, M&A, Investment Banking, Product Marketing, Alliance Management, Market Access, Operations, and Managed Markets, built on a B.S. from Cornell and an MBA from Columbia Business School. I have been fortunate to contribute to high-level strategic decisions at the Senior Management/Board levels while at Chase, Wyeth, Pfizer, Organon, Kos Pharmaceuticals, Novartis, Aralez, Lupin, Medexus and now Eyepoint. I have utilized my skills and experience to not only build a strong deal sheet, but importantly to also utilize strategy and insight for the discretion to walk when appropriate. I have managed strong teams while conducting strategic and transformational deals to create significant value. My breadth of experience has provided optimal evaluation and negotiation strategies, incorporating commercial and managed market perspectives into key decisions. I have developed a deep understanding of the pharmaceutical industry, the challenges that we face, both today and tomorrow, and strategies for the future of US healthcare. I’ve had the honor of speaking at industry conferences and panels, and have enjoyed volunteering my time to help others meet their goals. My strengths include my ability to critically analyze a situation, rapidly develop and evaluate solutions (both financially and strategically), build consensus, and clearly present recommendations to negotiate superior terms. I feel confident in my ability to tackle any challenge and feel strongly that there are "solutions" to all problems. I have developed a large professional network as I have been lucky to work with outstanding people through my career. My goal is to utilize my experience and skills at the most senior level to make impactful business decisions and grow my company.Specialties: Negotiations, strategic thinking, assessing/evaluating opportunities/challenges, financial analysis, creative terms, licensing, problem solving, networking
Listed skills include Pharmaceutical Industry, Strategy, Cross Functional Team Leadership, Biotechnology, and 41 others.
Current workplace
Michael Pine's current company
Company context helps verify the profile and gives searchers a useful next step.
16 roles
Michael Pine work experience
A career timeline built from the work history available for this profile.
Chief Business Officer
- Corporate Officer with broad responsibility for public biopharma with promising Phase II ophthalmology asset to provide long-term solutions in areas of ophthalmic unmet need- Leading Business & Corporate Development efforts for inlicensing, outlicensing, and other partnering initiatives- Responsible for corporate strategy and M&A as company evolves from commercially-focused company into development-stage biopharma organization focused on identifying and delivering new treatments using our leading, sustained-release intravitreal delivery to posterior segment technology
Chief Corporate Development & Strategy Officer
- Corporate Officer with broad responsibility for public biopharma with promising Phase II ophthalmology asset to provide long-term solutions in areas of ophthalmic unmet need- Leading Business & Corporate Development efforts for inlicensing, outlicensing, and other partnering initiatives- Responsible for corporate strategy and M&A as company evolves from commercially-focused company into development-stage biopharma organization focused on identifying and delivering new treatments using our leading, sustained-release intravitreal delivery to posterior segment technology
Jan 2022 - Oct 2023
Senior Vice President Business Development & Strategy
- Responsible for inorganic growth strategy and execution for growing public company with >C$100M in sales and positive adjusted EBITDA, focused on late stage and on-market assets for the North American market- Member of small management team aggressively seeking to grow via complementary partnerships and acquisitions, leveraging a strong commercial infrastructure in the US (Stem Cell Transplant, Rheumatology, Hematology, Oncology, Rare Disease) and Canada (GPs, Allergy, Specialty Oncology, Opportunistic)- Five transactions completed in first 9 months contributing to a 2.5x increase in market capitilzation and graduation to TSX Big Board
Sep 2020 - Jan 2022
Independent Bd Consultant
Independent Consultant
- BD Consultant for 4 companies; co-promotion, acquisition, platform technology and ex-US out-licensing- Successfully evaluated, negotiated and closed a co-promotion deal for Eyepoint (NASDAQ: EYPT) and reached negotiation stage with another company (confidential) over a 3 month period
Jun 2020 - Aug 2020
Senior Vice President Business Development - Global Specialty (Branded) Products
- Focused BD&L efforts to grow/evolve a ~$2.3B net sales, $5B+ mkt cap company into a leading branded, specialty pharmaceutical company- Responsible for identifying, evaluating, negotiating and executing licenses, acquisitions, spin-outs, joint ventures, co-promotions, and other creative structures- Negotiated and closed a deal for a complementary women's health asset
Feb 2019 - May 2020
Vice President, Corporate Development & Licensing
- Identified, evaluated, negotiated and completed six transactions for up to $340M- Responsible for developing and executing inorganic growth strategy for entrepreneurial, commercial stage public pharmaceutical company, backed by Deerfield Partners- Led cross-functional team, evaluating over 150 opportunities, 30 diligences and 13 negotiations- Hired and directed Sr. Director of CD&L to manage alliances and expand therapeutic platform
Aug 2015 - Jan 2019
Director, Head Of Operations & Analytics, Us Managed Markets
- Provided strategic insight and direction for US Managed Markets including payer marketing, pricing & contracting, supply & distribution, and account management - Led team of 5 direct and 7 indirect reports; department responsbilities include coordination of budget, IT, training, analytics, communications, HR. - Member of management team, leading and overseeing up to 1,000 colleagues.- Created presentations and speeches for VP USMM; represented USMM cross-functionally throughout organization
Dec 2013 - Jul 2015
Director, Market Access Strategies, Us Managed Markets
- Developed and implemented market access strategies for Gilenya, Fanapt, TOBI, Serelaxin- Created and implemented innovative pricing and access strategy for TOBI Podhaler launch- Led 2, 25+ person cross-functional teams including Pharmacy, Patient Services, Adherence- Directed analysis and HEOR to develop value proposition and materials to optimize access- Developed pricing and contracting strategies to maximize profitability - high level of success in 2013 resulted in excellent access and exceeded budgetary goals.
Aug 2011 - Dec 2013
Marketing & Alliance Management
- Head of Alliance Management on 2 marketed pharmaceutical products (womens health) and Brand Management for a third pharmaceutical launch brand (psychiatry) within the Neuro/Psych Operating Unit.• Fanapt (iloperidone), launch brand: Peer to Peer/KOL programs, war gaming, brand strategy• Vivelle Dot (estradiol patch): Alliance manager, negotiator for Novogyne Joint Venture• Comtan/Stalevo (entacapone): Professional and consumer marketing, contest development• Member of Novogyne Management Committee; Budget and P&L approval responsibilities
Feb 2010 - Aug 2011
Director, Us Business Development & Licensing
• Lead for sourcing, evaluating and negotiating licensing and co-promotion projects• Represented US interests in internal and external negotiations for global partnerships• Received Business Excellence Award for leading and closing Elidel Co-Promotion• Novartis Leadership Program, Executive Diversity & Inclusion Committee, Leading Innovation• Responsible for due diligence, creative deal structures, problem solving, M&A assessments
Apr 2007 - Jul 2011
Director, Business Development & Licensing
Shared responsibility for all licensing, partnering, alliance management, acquisition and divestiture activity for Kos Pharmaceuticals, ranked #6 on Fortune Magazine's fastest growing companies.
Jan 2006 - Mar 2007
Director Of Business Development
• Responsible for all corporate sourcing, evaluating, and negotiating for strategic partnerships • Manager of industry-leading Women’s Health Care global business development efforts • Led matrixed teams in assessing and prioritizing opportunities in numerous therapeutic areas.
Aug 2004 - Jan 2006
Senior Manager - New Product Development Licensing & Acquisitions
Analysis of in and out-licensing opportunities, creation of deal terms, aid in negotiation of acquisitions of drug candidates from other pharma/biotech companies, analysis of acquisition opportunities, internal consulting and problem solving on complex operational issues, overall strategy development for licensing portfolio
Nov 2001 - Aug 2004
Assistant Brand Manager
• Used problem solving and research skills to create marketing plan, forecast sales and plan media budget for a new “Advil Cold & Sinus” product; participated in DTC planning for “Advil Flu”• Managed cross-functional team of sales, media, product development and research
May 2000 - Aug 2000
Sr. Financial Analyst
• Performed analysis, valuations and financial modeling on various companies for possible mergers and acquisitions; communicated results to senior management teams• Produced pitch books, prospectuses, and sales memoranda raising over $2 billion
Jul 1997 - Aug 1999
2 education records
Michael Pine education
Mba, Strategy, Marketing, Management, Finance
Columbia Business School
Bs, Economics, Pre-Med, Marketing
Cornell University
FAQ
Frequently asked questions about Michael Pine
Quick answers generated from the profile data available on this page.
What company does Michael Pine work for?
Michael Pine works for Pine Health Strategies, LLC.
What is Michael Pine's role at Pine Health Strategies, LLC?
Michael Pine is listed as Chief Executive Officer at Pine Health Strategies, LLC.
What is Michael Pine's email address?
AeroLeads has found 1 work email signal at @eyepointpharma.com for Michael Pine at Pine Health Strategies, LLC.
What is Michael Pine's phone number?
AeroLeads has found 10 phone signal(s) with area code 212, 718, 732, 914, 516, 607, 862 for Michael Pine at Pine Health Strategies, LLC.
Where is Michael Pine based?
Michael Pine is based in New York City Metropolitan Area, United States while working with Pine Health Strategies, LLC.
What companies has Michael Pine worked for?
Michael Pine has worked for Pine Health Strategies, Llc, Eyepoint Pharmaceuticals, Medexus Pharmaceuticals, Inc., Independent Consultant, and Lupin Pharmaceuticals.
How can I contact Michael Pine?
You can use AeroLeads to view verified contact signals for Michael Pine at Pine Health Strategies, LLC, including work email, phone, and LinkedIn data when available.
What schools did Michael Pine attend?
Michael Pine holds Mba, Strategy, Marketing, Management, Finance from Columbia Business School.
What skills is Michael Pine known for?
Michael Pine is listed with skills including Pharmaceutical Industry, Strategy, Cross Functional Team Leadership, Biotechnology, Business Development, Product Launch, Mergers And Acquisitions, and Market Access.
Find 750M verified contacts
Search by job title, company, industry, location, and seniority. Export verified B2B contact data when you need it.
Start free trial